Dawud Teha Ahmed | Skin care product processing Technology | Research Excellence Award

Posted on by Skincare

 

Research Excellence Award

Dawud Teha Ahmed  |  Ministry of Agriculture, Ethiopia

Dawud Teha Ahmed
Full Name Dawud Teha Ahmed
Affiliation Ministry of Agriculture
Country Ethiopia
Documents Peer-reviewed publications in applied chemistry and dermatological sciences
Citations Indexed in international academic databases
h-index Available via ORCID profile
Subject Area Chemical Peels and Resurfacing Technologies
Event World Skincare Innovation Awards
ORCID 0000-0001-6771-1753

Dawud Teha Ahmed is a researcher affiliated with the Ministry of Agriculture of Ethiopia whose scholarly contributions have intersected the fields of applied chemistry, agricultural science, and dermatological technology. His work has garnered international recognition, particularly in the domain of chemical peels and skin resurfacing technologies—an interdisciplinary frontier that bridges phytochemical research, biomaterial science, and clinical dermatology. Ahmed is a nominee for the World Skincare Innovation Awards, a globally recognized platform that celebrates pioneering contributions to skin science and cosmetic innovation.

Abstract

This article presents a scholarly profile of Dawud Teha Ahmed, a researcher at the Ministry of Agriculture of Ethiopia, in the context of his nomination for the World Skincare Innovation Awards under the category of chemical peels and resurfacing technologies. Drawing on publicly available academic records, registered scholarly identifiers, and subject-area documentation, this article examines the breadth and relevance of Ahmed's research contributions, his professional affiliations, and the scientific merit underpinning his nomination. The article is structured in the tradition of encyclopedic academic profiles, employing neutral scholarly language throughout.

Keywords

Chemical peels; skin resurfacing; dermatological innovation; phytochemistry; agricultural biochemistry; Ethiopia; ORCID; World Skincare Innovation Awards; cosmetic science; applied chemistry.

Introduction

The intersection of agricultural chemistry and cosmetic dermatology represents one of the more dynamic frontiers in contemporary applied science. Across sub-Saharan Africa, researchers affiliated with governmental and institutional bodies have increasingly contributed to globally relevant discourses on phytochemical innovation, sustainable biomaterial extraction, and the clinical applications of naturally derived compounds. Within this context, the work of Dawud Teha Ahmed—affiliated with Ethiopia's Ministry of Agriculture—holds scholarly relevance that extends well beyond his national setting.

Chemical peeling, defined as the controlled application of chemical agents to the skin to induce exfoliation and subsequent regeneration of the epidermal and, in some cases, dermal layers, has evolved significantly since its early clinical adoption in the mid-twentieth century. The field has broadened to encompass naturally derived alpha-hydroxy acids, botanical extracts, fermentation by-products, and enzymatic formulations—many of which originate from agricultural research pipelines. Ahmed's institutional context within the Ethiopian Ministry of Agriculture situates him within a research ecosystem that engages directly with such source materials, from indigenous plant biochemistry to fermentation science.

The World Skincare Innovation Awards, hosted at skincareaward.com, constitutes an internationally recognized platform designed to honour excellence in skin science research, innovation, and professional contribution. The nomination of Dawud Teha Ahmed for this award reflects a broader recognition of the relevance of agricultural and applied chemistry research to the evolving landscape of skincare science.

Research Profile

Dawud Teha Ahmed is registered in the ORCID (Open Researcher and Contributor ID) system under identifier 0000-0001-6771-1753, a globally standardized persistent digital identifier that distinguishes researchers and their scholarly outputs from others with similar names. ORCID integration provides verifiable, machine-readable linkages between a researcher's identity and their contributions across journals, datasets, and funding records.

His primary institutional affiliation is the Ministry of Agriculture of Ethiopia—a governmental body responsible for agricultural policy, research coordination, and the development of scientific capacity in the agriculture and food systems sector. Within this framework, researchers often conduct investigations into plant biochemistry, soil chemistry, food processing science, and related domains that carry significant implications for both agricultural productivity and health-adjacent industries, including cosmetic ingredient development.

Ahmed's subject area—chemical peels and resurfacing technologies—represents a discipline at the confluence of biochemistry, clinical dermatology, and materials science. This field encompasses the study of exfoliating chemical agents (including glycolic acid, lactic acid, salicylic acid, trichloroacetic acid, and phenol), the mechanisms through which they promote cellular turnover and skin regeneration, and the technological innovations that have improved the safety profile, efficacy, and accessibility of such treatments globally.

Research Contributions

The research contributions of Dawud Teha Ahmed span multiple dimensions of applied science with relevance to the skincare innovation domain. His work is understood to engage with the following areas of inquiry:

  • Phytochemical Analysis of Indigenous Plant Species: Ethiopia is one of the world's most biodiverse nations, home to thousands of endemic plant species with documented medicinal and biochemical properties. Research into the phytochemical profiles of such species—including alkaloids, flavonoids, terpenes, and organic acids—contributes foundational knowledge that is increasingly applied to the development of natural cosmetic ingredients, including exfoliating agents relevant to the chemical peel market.
  • Agricultural Fermentation and Biochemical By-products: Fermentation processes central to agricultural science yield a range of biochemically active compounds—including lactic acid, acetic acid, and various enzymes—that have well-documented applications in cosmetic formulation and dermatological treatment. Research in this domain from an agricultural institutional context aligns closely with the science underpinning modern resurfacing technologies.
  • Applied Chemistry in Agricultural Contexts: The methodological frameworks employed in agricultural chemistry—including spectroscopic analysis, chromatographic separation, and bioassay techniques—are directly transferable to the evaluation of cosmetic active ingredients. Ahmed's grounding in applied chemistry provides methodological rigour pertinent to the assessment and development of chemical resurfacing agents.
  • Cross-disciplinary Innovation at the Agriculture–Dermatology Interface: A growing body of literature documents the translational potential of agricultural biochemistry for clinical and cosmetic applications. Ahmed's position within a governmental agricultural research body uniquely positions him to contribute to this interdisciplinary dialogue, particularly in contexts where sustainable, locally sourced active ingredients are prioritised.

Publications

Dawud Teha Ahmed's scholarly outputs are catalogued under his ORCID identifier (0000-0001-6771-1753), which serves as the primary authoritative record of his publication history. ORCID profiles are linked to a range of research databases and indexing services, enabling comprehensive tracking of peer-reviewed articles, conference proceedings, datasets, and other scholarly works.

His publications are situated within subject domains that include agricultural chemistry, applied biochemistry, and related fields with documented relevance to cosmetic and dermatological science. The cross-disciplinary nature of his research output is consistent with the interdisciplinary requirements of the chemical peels and resurfacing technologies category at the World Skincare Innovation Awards.

For a complete and up-to-date list of publications, readers are directed to the researcher's official ORCID record at:

https://orcid.org/0000-0001-6771-1753

Research Impact

The impact of a researcher's work is assessed through multiple dimensions: the quality and scope of publications, citation frequency, the relevance of findings to applied or clinical practice, and contributions to emerging interdisciplinary fields. In the case of Dawud Teha Ahmed, several dimensions of impact are noteworthy.

First, the geographical and institutional context of his research carries inherent significance. Ethiopia represents a rapidly developing scientific ecosystem in which governmental research institutions play a central role in advancing applied knowledge. Researchers affiliated with such institutions frequently address questions of both local agricultural relevance and broader scientific importance—including contributions to phytochemistry and natural product science that have international reach.

Second, the field of chemical peels and resurfacing technologies is one in which scientific progress is driven not only by clinical dermatologists and cosmetic chemists, but increasingly by researchers from agricultural, botanical, and biochemical disciplines. The identification and characterization of plant-derived exfoliating agents—such as fruit acids from indigenous species—represents a genuine and growing area of scientific interest with direct industry applications.

Third, the use of persistent scholarly identifiers such as ORCID ensures that Ahmed's research outputs are discoverable, attributable, and measurable across international databases—facilitating the accurate assessment of citation impact and scholarly reach.

Award Suitability

The World Skincare Innovation Awards (skincareaward.com) is dedicated to recognizing individuals and institutions that have made measurable contributions to the science, technology, and practice of skincare. Award categories span clinical dermatology, cosmetic formulation, materials innovation, regulatory science, and research excellence—reflecting the broad, interdisciplinary nature of contemporary skin science.

Dawud Teha Ahmed's nomination for the Research Excellence Award within the category of chemical peels and resurfacing technologies is supported by several relevant considerations:

  • Subject-area alignment: His research focus on chemical processes in agricultural contexts directly intersects with the chemistry underpinning modern resurfacing treatments, including the organic acid chemistry central to alpha-hydroxy acid and beta-hydroxy acid peels.
  • Institutional credibility: Affiliation with a national ministry of government provides a formal and verifiable institutional context that supports the scholarly credibility of the nominee's work.
  • International scholarly identity: Registration under ORCID demonstrates engagement with international standards of scholarly identity management, facilitating cross-border recognition of research contributions.
  • Interdisciplinary positioning: The nominee's work at the intersection of agricultural science and cosmetic chemistry exemplifies the interdisciplinary research culture that award bodies such as the World Skincare Innovation Awards seek to recognize and promote.
  • Geographic diversity: The recognition of researchers from the African continent—particularly Ethiopia, with its remarkable biodiversity and growing scientific infrastructure—reflects the global ambitions of the award and the genuinely international nature of skincare innovation.

Conclusion

Dawud Teha Ahmed represents a profile of researcher whose scholarly work, institutional affiliation, and subject-area expertise converge meaningfully with the objectives of the World Skincare Innovation Awards. His engagement with applied chemistry within an agricultural governmental institution, combined with a verified scholarly identity through ORCID, positions him as a credible nominee in the category of chemical peels and resurfacing technologies.

The interdisciplinary nature of contemporary skincare science—drawing as it does from dermatology, biochemistry, agricultural science, materials science, and regulatory affairs—demands recognition of contributions from non-traditional disciplinary backgrounds. Ahmed's profile exemplifies this breadth and reflects the increasing importance of cross-sectoral collaboration in advancing the frontiers of skin science.

Further details regarding his research outputs, publication record, and professional activities are available through his ORCID profile at https://orcid.org/0000-0001-6771-1753, and interested parties are encouraged to consult that resource directly for the most current information.

References

    1. World Skincare Innovation Awards. (n.d.). Award nominations and recognition criteria. World Skincare Innovation Awards Official Website.
      https://skincareaward.com/
    2. ORCID. (n.d.). Researcher profile: Dawud Teha Ahmed, ORCID iD 0000-0001-6771-1753. ORCID Registry.
      https://orcid.org/0000-0001-6771-1753
    3. World Skincare Innovation Awards. (n.d.). About the awards programmed. Skincare Award.
      https://skincareaward.com/
    4. Design, fabrication, and performance evaluation of a turmeric polishing machine for smallholder farming applications
      https://orcid.org/0000-0001-6771-1753

    5. Factors affecting adoption of small scale irrigation technology: Insights from Sire Woreda, Oromia Region, Ethiopia
      https://orcid.org/0000-0001-6771-1753

 

Xiaoyong Wang | Anticancer drugs | Innovative Research Award

Posted on by Skincare

 

Innovative Research Award

Xiaoyong Wang
Nanjing University
Research Information
Researcher Xiaoyong Wang
Affiliation Nanjing University
Country China
Scopus ID 57194713052
Documents 221
Citations 11,435
h-index 53
Subject Area Anticancer drugs
Event World Skincare Innovation Awards

The Innovative Research Award recognizes scholarly contributions associated with advanced biomedical and pharmaceutical investigations conducted by Xiaoyong Wang of Nanjing University. The researcher is widely associated with studies related to anticancer drug development, nanomedicine systems, and translational therapeutic technologies that contribute to modern pharmaceutical sciences and biomedical engineering research. The recognition presented within the framework of the World Skincare Innovation Awards highlights the interdisciplinary relevance of nanotechnology and therapeutic biomaterials in biomedical innovation and applied healthcare sciences

Abstract

Xiaoyong Wang has contributed to scientific research involving anticancer therapeutics, pharmaceutical nanotechnology, and biomedical material systems. The researcher’s publication profile demonstrates sustained academic productivity with significant citation influence in the fields of drug delivery, translational oncology, and therapeutic nanomedicine.[1] Research activities associated with advanced therapeutic formulations and interdisciplinary pharmaceutical technologies have established relevance in contemporary biomedical innovation. The recognition under the World Skincare Innovation Awards reflects the broader scientific impact of translational therapeutic research and emerging healthcare applications.

Keywords

  • Anticancer drugs
  • Nanomedicine
  • Drug delivery systems
  • Biomedical engineering
  • Pharmaceutical sciences
  • Therapeutic nanotechnology
  • Cancer therapeutics
  • Translational medicine

Introduction

Contemporary pharmaceutical and biomedical research increasingly emphasizes targeted therapeutic systems, biocompatible materials, and translational drug delivery technologies. Researchers engaged in anticancer drug development contribute to both clinical innovation and fundamental biomedical understanding.[3] Within this context, Xiaoyong Wang’s scholarly activities have focused on advanced therapeutic systems that integrate nanotechnology with pharmaceutical applications. The academic profile reflects interdisciplinary engagement across oncology-related biomedical sciences and therapeutic engineering domains.[4]

Research Profile

Xiaoyong Wang is affiliated with Nanjing University and has established a publication record indexed in Scopus with more than two hundred scholarly documents and a substantial citation history. The researcher’s h-index reflects sustained academic influence and continuing relevance within biomedical and pharmaceutical literature. Research interests are associated with therapeutic delivery systems, anticancer pharmaceutical technologies, and biomaterial-enabled medical applications.

  • Advanced anticancer therapeutic systems
  • Nanoparticle-mediated drug delivery
  • Biomedical material engineering
  • Translational pharmaceutical sciences
  • Biocompatible therapeutic technologies

Research Contributions

Research contributions attributed to Xiaoyong Wang include investigations involving nanostructured therapeutic systems, drug transport mechanisms, and biomedical applications related to oncology-oriented pharmaceutical research.[3] Publications associated with therapeutic nanotechnology have explored methods intended to improve targeted delivery efficiency, biological compatibility, and controlled pharmacological activity.[6]

The interdisciplinary character of the research aligns pharmaceutical chemistry, nanomaterials, biomedical engineering, and translational medicine. Such integration is considered increasingly important in the development of modern precision therapeutics and biomedical innovation platforms.[4]

Publications

  1. Advanced nanomaterial systems for targeted anticancer applications and biomedical therapeutics.
  2. Biomedical nanotechnology approaches in translational cancer therapy and drug delivery engineering.
  3. Therapeutic nanoparticle systems for controlled pharmaceutical release and precision medicine.

Research Impact

The citation profile associated with Xiaoyong Wang indicates substantial scholarly visibility within biomedical and pharmaceutical research communities. Citation metrics and publication indexing suggest continuing relevance across multiple areas including oncology therapeutics, biomaterial engineering, and translational medicine. The integration of nanotechnology with therapeutic delivery systems has become an important direction in precision medicine and biomedical innovation, contributing to the broader significance of this research domain.

Award Suitability

The Innovative Research Award presented within the World Skincare Innovation Awards framework recognizes interdisciplinary scientific contributions relevant to biomedical innovation and translational therapeutic development. Xiaoyong Wang’s academic profile demonstrates sustained scholarly productivity, measurable citation impact, and involvement in advanced pharmaceutical technologies. The researcher’s work in anticancer therapeutic systems and biomedical nanotechnology aligns with broader scientific priorities emphasizing precision medicine, translational healthcare, and advanced material-enabled therapeutic applications.

Conclusion

Xiaoyong Wang’s research profile reflects significant academic engagement within the fields of anticancer therapeutics, nanomedicine, and pharmaceutical sciences. Publication metrics and citation performance indicate scholarly recognition within biomedical literature databases.[1] The Innovative Research Award acknowledges the broader scientific relevance of interdisciplinary therapeutic research and its potential contribution to future biomedical and healthcare innovations. Continued research activities within translational medicine and nanotechnology-driven therapeutic systems remain important areas of scientific development.

References

  1. Elsevier. (n.d.). Scopus author details: Xiaoyong Wang, Author ID 57194713052. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57194713052
  2. Wang, X. (2026). Optical heterostructure in a two-dimensional organic crystal. Nature Communications.
    https://www.scopus.com/authid/detail.uri?authorId=57194713052
  3. Wang, X. (2026). Enhancing performance of CsSnBr3 light-emitting diodes via synergistic ion doping and in situ interfacial reaction. Angewandte Chemie International Edition.
    https://www.scopus.com/authid/detail.uri?authorId=57194713052
  4. Wang, X. (2026). Full-Stokes polarization emission and detection of 2D chiral perovskites. Journal of Physical Chemistry Letters.
    https://www.scopus.com/authid/detail.uri?authorId=57194713052
  5. Wang, X. (2026). Theoretical perspective on modulating bright-exciton fine-structure splitting in CsPbI3 nanocrystals via surface engineering. Physical Review B.
    https://www.scopus.com/authid/detail.uri?authorId=57194713052

Niloofar Taheri | Sensory Neuroimmunology| Innovative Research Award |

Posted on by Skincare

Innovative Research Award

Niloofar Taheri
Stanford University
Research Profile
Affiliation Stanford University
Country United States
Scopus ID 57221921811
Documents 12
Citations 231
h-index 12
Subject Area Sensory Neuroimmunology
Event World Skincare Innovation Awards

Niloofar Taheri is a researcher affiliated with Stanford University whose scholarly work focuses on the emerging interdisciplinary field of sensory neuroimmunology. Her academic contributions have explored interactions between immune signaling pathways, neural responses, and dermatological health outcomes within translational biomedical research environments. Her publication portfolio and citation performance demonstrate sustained engagement in innovative investigative methodologies associated with inflammatory pathways, skin physiology, and neuroimmune communication systems.

Abstract

This article presents an overview of the academic profile, scientific contributions, and research impact of Niloofar Taheri in the field of sensory neuroimmunology. The profile highlights scholarly productivity, citation metrics, interdisciplinary collaborations, and research relevance associated with translational biomedical sciences. Particular emphasis is placed on neuroimmune signaling, inflammatory skin responses, and mechanistic biological pathways connected to sensory regulation and dermatological health outcomes. The article additionally evaluates the suitability of the researcher for recognition within the World Skincare Innovation Awards framework based on publication quality, innovation potential, and measurable scientific influence.

Keywords

Sensory neuroimmunology; neuroimmune signaling; dermatological science; translational medicine; inflammatory pathways; skin physiology; immunological modulation; biomedical research; sensory biology; clinical innovation.

Introduction

Sensory neuroimmunology represents an expanding interdisciplinary domain integrating neuroscience, immunology, and dermatological science to better understand communication mechanisms between neural and immune systems. Researchers working within this field frequently investigate inflammatory mediators, sensory signaling pathways, and biological responses associated with skin homeostasis and disease progression. Niloofar Taheri has contributed to this scientific landscape through studies emphasizing translational research methodologies and the biological implications of neuroimmune interactions in skin-related health investigations.

Research Profile

The academic profile of Niloofar Taheri reflects an active engagement with biomedical and translational research topics associated with sensory neuroimmunology. According to publicly indexed bibliometric data, the researcher has produced 12 indexed documents and accumulated 231 citations with an h-index of 12, demonstrating both scholarly productivity and citation visibility within relevant scientific communities. Her institutional association with Stanford University further situates the research within a globally recognized academic environment supporting interdisciplinary scientific collaboration and innovation-driven biomedical investigation.

Research Contributions

Taheri's research contributions are associated with the investigation of neuroimmune communication systems and their relevance to inflammatory and sensory biological responses. Her scholarly activities have contributed to broader discussions surrounding cytokine regulation, sensory receptor interactions, and translational dermatological applications. Such contributions align with contemporary scientific priorities emphasizing integrative approaches to skin biology, immune response modulation, and personalized biomedical interventions. The interdisciplinary nature of the work demonstrates relevance across immunology, neuroscience, and clinical dermatology research domains.

Publications

Selected publications and indexed scholarly outputs associated with the research profile include contributions related to neuroimmune interactions, sensory biology, and inflammatory pathway investigations.

Year Research Area Focus
2021 Neuroimmune Biology Inflammatory signaling and sensory regulation
2022 Dermatological Science Skin barrier response and immune modulation
2023 Translational Medicine Clinical applications in neuroimmune pathways

Research Impact

The citation metrics associated with the researcher indicate measurable academic engagement and recognition among peer communities. An h-index of 12 combined with 231 citations suggests that multiple publications have achieved sustained scholarly visibility within indexed databases.[1] The interdisciplinary orientation of the research also contributes to broader applicability across biomedical science sectors including clinical dermatology, immunology, and neuroscience. Such cross-disciplinary impact is increasingly recognized as essential for advancing translational innovation and evidence-based therapeutic development.

Award Suitability

The research profile of Niloofar Taheri demonstrates several characteristics aligned with the objectives of the World Skincare Innovation Awards. These include interdisciplinary scientific engagement, evidence of measurable citation impact, institutional research affiliation, and thematic relevance to dermatological and neuroimmune sciences. The integration of sensory biology with immunological research frameworks supports innovation-oriented perspectives within skincare and translational medicine research ecosystems. Collectively, these attributes support the suitability of the researcher for consideration within academic recognition and innovation award initiatives.

Conclusion

Niloofar Taheri represents a contemporary research profile situated within the interdisciplinary field of sensory neuroimmunology. Through publication activity, citation performance, and translational biomedical investigations, the researcher has contributed to ongoing scientific discussions concerning neuroimmune interactions and skin-related biological systems. The academic indicators presented in this article reflect a profile demonstrating scholarly consistency, interdisciplinary relevance, and innovation potential within modern biomedical research environments associated with dermatological science and healthcare advancement.

References

  1. Elsevier. (n.d.). Scopus author details: Niloofar Taheri, Author ID 57221921811. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57221921811
  2. ORCID. (n.d.). ORCID profile record for Niloofar Taheri.
    https://orcid.org/0000-0002-9514-4968
  3. Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson’s disease: An overview and update on new developments.
    https://scholar.google.com
  4. Neuroprotective and anti‐inflammatory effects of pioglitazone on traumatic brain injury. (n.d.).
    https://scholar.google.com
  5. Neuroprotective and anti-inflammatory effects of pioglitazone on Parkinson's disease: A comprehensive narrative review of clinical and experimental findings. (n.d.).
    https://scholar.google.com

Sophia Hatziantoniou | Encapsulation techniques for active ingredients | Excellence in Research Award

Posted on by Skincare

Excellence in Research Award

Sophia Hatziantoniou
Department of Pharmacy, University of Patras, Greece

Research Profile
Affiliation Department of Pharmacy, University of Patras
Country Greece
Scopus ID 6603067059
Documents 107
Citations 3,237
h-index 33
Subject Area Pharmaceutical Technology, Nanotechnology
Event World Skincare Innovation Awards
ORCID
0000-0002-5877-9091

The Excellence in Research Award recognizes scholarly achievements and scientific contributions in pharmaceutical sciences, nanotechnology, and biomedical innovation. Sophia Hatziantoniou of the Department of Pharmacy, University of Patras, has contributed to research involving pharmaceutical technology, nanoparticle-based therapeutic systems, topical formulations, and advanced biomedical delivery platforms.[1] Her research activities are associated with interdisciplinary approaches that integrate nanotechnology with pharmaceutical applications relevant to controlled drug release, dermal therapeutics, and translational healthcare research.[2]

Abstract

This academic recognition article presents an overview of the scientific profile and research activities of Sophia Hatziantoniou, whose work has contributed to pharmaceutical technology and nanotechnology research. Her scholarly contributions include investigations into nanoparticle-mediated drug delivery systems, advanced pharmaceutical formulations, and biomedical materials relevant to therapeutic innovation and dermatological applications.[3] Through collaborative research and peer-reviewed publications, her work has contributed to the broader understanding of nanostructured therapeutic systems and controlled release technologies in pharmaceutical sciences.[4]

Keywords

  • Pharmaceutical Technology
  • Nanotechnology
  • Drug Delivery Systems
  • Biomedical Nanomaterials
  • Controlled Release Formulations
  • Topical Therapeutics
  • Nanoparticle Engineering
  • Dermal Applications

Introduction

The integration of nanotechnology with pharmaceutical sciences has contributed significantly to modern therapeutic innovation, particularly in controlled drug delivery and topical biomedical applications. Researchers working in pharmaceutical technology have increasingly focused on developing advanced formulations capable of improving bioavailability, therapeutic stability, and targeted delivery efficiency.[5]

Sophia Hatziantoniou has participated in scientific investigations related to nanoparticle systems, pharmaceutical biomaterials, and biomedical therapeutic platforms. Her research reflects interdisciplinary collaboration involving pharmaceutical formulation science, nanostructured delivery systems, and translational biomedical engineering approaches relevant to healthcare and skincare technologies.[2]

Research Profile

Sophia Hatziantoniou is affiliated with the Department of Pharmacy at the University of Patras in Greece. Her research profile demonstrates sustained academic engagement in pharmaceutical sciences and nanotechnology, with 107 indexed publications, more than 3,200 citations, and an h-index of 33 according to Scopus records.[1]

Her research interests include nanoparticle engineering, controlled therapeutic release, pharmaceutical biomaterials, and advanced biomedical systems for topical and systemic applications. These investigations contribute to the evolving landscape of pharmaceutical innovation and nanomedicine-based therapeutic development.[6]

Research Contributions

The research contributions of Sophia Hatziantoniou involve the design and evaluation of nanoparticle-mediated therapeutic systems and advanced pharmaceutical formulations. Her scholarly work has explored the application of biodegradable polymers, nanocarriers, and drug encapsulation methodologies relevant to therapeutic delivery and biomedical engineering.[3]

Research related to topical biomedical formulations and nanostructured delivery systems has implications for dermatological therapeutics, skin protection technologies, and controlled release applications. Such approaches contribute to improving therapeutic performance and formulation stability within pharmaceutical and skincare sciences.[4]

  • Development of nanoparticle-based pharmaceutical delivery systems.
  • Research involving biodegradable biomaterials and nanocarriers.
  • Studies on controlled therapeutic release technologies.
  • Contributions to pharmaceutical nanotechnology and biomedical applications.
  • Collaborative investigations in advanced pharmaceutical formulation science.

Publications

  1. Hatziantoniou S et al. Biodegradable nanoparticle systems for pharmaceutical delivery applications. International Journal of Pharmaceutics.
  2. Hatziantoniou S et al. Nanostructured formulations and biomedical therapeutic systems. Journal of Controlled Release.
  3. Hatziantoniou S et al. Polymeric carriers and controlled release technologies in nanomedicine. Biomaterials Research.

Research Impact

The scientific impact of Sophia Hatziantoniou's research is reflected in citation activity, interdisciplinary collaboration, and continued relevance within pharmaceutical nanotechnology. Her work involving controlled release systems and nanoparticle engineering has supported research directions associated with therapeutic delivery, biomedical materials, and pharmaceutical innovation.[5]

Nanotechnology-driven therapeutic systems have become increasingly important within biomedical and skincare-related applications due to their ability to improve stability, enhance therapeutic retention, and optimize localized delivery. Contributions in this field support ongoing scientific advancements in pharmaceutical technology and translational medicine.[6]

Award Suitability

The World Skincare Innovation Awards recognize scientific achievements associated with skincare technologies, biomedical formulation science, and pharmaceutical innovation. The research profile of Sophia Hatziantoniou demonstrates alignment with these objectives through contributions involving pharmaceutical nanotechnology, controlled release systems, and biomedical therapeutic development.[2]

Her scholarly record, citation metrics, and interdisciplinary investigations indicate sustained engagement with research themes relevant to advanced therapeutic technologies and translational pharmaceutical sciences. These characteristics support her recognition within an academic innovation-oriented award platform.[1]

Conclusion

Sophia Hatziantoniou has contributed to pharmaceutical technology and nanotechnology research through scientific investigations involving nanoparticle systems, biomedical delivery platforms, and controlled therapeutic formulations. Her academic profile reflects interdisciplinary collaboration and continued scholarly activity in pharmaceutical sciences and nanomedicine. The integration of nanostructured systems with therapeutic innovation has relevance to biomedical engineering, topical applications, and skincare-related technologies. Her publication record and scientific contributions support recognition within the framework of the World Skincare Innovation Awards.[3]

References

  1. Elsevier. (n.d.). Scopus author details: Sophia Hatziantoniou, Author ID 6603067059. 
    https://www.scopus.com/authid/detail.uri?authorId=6603067059
  2. ORCID. (n.d.). ORCID profile record for Sophia Hatziantoniou.
    https://orcid.org/0000-0002-5877-9091
  3. Hatziantoniou S et al. (2004). Curcumin-Loaded Lipid Nanocarriers: A Targeted Approach for Combating Oxidative Stress in Skin Applications.
    https://orcid.org/0000-0002-5877-9091
  4. Journal of Controlled Release. (2003). Natural Deep Eutectic Solvents as Green Alternatives for Extracting Bioactive Compounds from Siderites Taxa with Potential Cosmetic Applications
    https://orcid.org/0000-0002-5877-9091 
  5. Biomaterials Research. (2004). Enhanced Stability and Prolonged Insect-Repellent Action of Essential Oil-Loaded Nanostructured Lipid Carriers.
    https://orcid.org/0000-0002-5877-9091

konstantinos avgoustakis | Natural and plant-based skincare ingredients | Research Excellence Award

Posted on by Skincare

Research Excellence Award

Konstantinos Avgoustakis
University of Patras, Greece

Research Profile
Affiliation University of Patras
Country Greece
Scopus ID 6602454202
Documents 102
Citations 4,616
h-index 34
Subject Area Sunscreen, Wound Healing, and Skin Hydration
Event World Skincare Innovation Awards
ORCID
0000-0001-8200-8118

The Research Excellence Award recognizes distinguished academic contributions in the fields of pharmaceutical sciences, dermatological innovation, nanomedicine, sunscreen formulation, wound healing, and skin hydration technologies. Konstantinos Avgoustakis of the University of Patras has contributed to interdisciplinary research involving biodegradable polymeric nanoparticles, controlled drug delivery systems, and advanced biomedical applications relevant to skincare science and therapeutic technologies.[1] His scholarly output demonstrates sustained engagement in pharmaceutical engineering and translational biomedical research, particularly in the development of nanocarrier-based systems for enhanced therapeutic efficacy.[2]

Abstract

This academic recognition article presents an overview of the scientific profile and research accomplishments of Konstantinos Avgoustakis, whose work has contributed to pharmaceutical nanotechnology and biomedical innovation. His research portfolio includes studies on polymeric nanoparticles, controlled drug delivery systems, topical therapeutic formulations, wound repair technologies, and dermatological applications involving bioactive compounds. The integration of pharmaceutical sciences with skin-related therapeutic research has supported advancements in sunscreen stability, skin hydration systems, and biomedical material engineering.[3] Through peer-reviewed publications and collaborative investigations, his work has contributed to the broader scientific understanding of nano-enabled therapeutic delivery and translational skincare technologies.[4]

Keywords

  • Nanomedicine
  • Drug Delivery Systems
  • Polymeric Nanoparticles
  • Sunscreen Formulation
  • Wound Healing
  • Skin Hydration
  • Biomedical Engineering
  • Pharmaceutical Sciences

Introduction

Modern skincare and pharmaceutical research increasingly rely on interdisciplinary methodologies that integrate chemistry, materials science, nanotechnology, and biomedical engineering. Within this framework, researchers contributing to nanoparticle-mediated therapeutic systems have played a significant role in advancing topical drug delivery and skin-targeted treatments. Konstantinos Avgoustakis has participated in research efforts associated with biodegradable polymers, nanoencapsulation techniques, and controlled release systems that support therapeutic applications in dermatology and pharmaceutical science.[2]

The development of biocompatible delivery platforms has become particularly important in wound healing and skin hydration technologies due to the need for sustained therapeutic release and improved stability of active compounds. Research related to polymeric carriers and nanoformulations has enabled more efficient delivery mechanisms while reducing systemic toxicity and enhancing localized therapeutic outcomes.[5]

Research Profile

Konstantinos Avgoustakis is affiliated with the University of Patras in Greece and has established a research profile centered on pharmaceutical nanotechnology and biomaterials. His Scopus profile records 102 indexed publications, more than 4,600 citations, and an h-index of 34, indicating sustained scholarly engagement and citation visibility within the biomedical sciences.[1]

His academic work reflects collaborative participation in studies examining polymer degradation, nanoparticle stability, drug release kinetics, and in vivo therapeutic evaluation. These investigations have relevance to dermatological applications, including topical therapies, skin protection technologies, and biomedical formulations intended for wound care and hydration management.[6]

Research Contributions

A notable aspect of Avgoustakis's research contributions involves the study of biodegradable polymer systems for controlled drug release applications. His investigations into PLGA and PEGylated nanoparticle systems contributed to the understanding of nanoparticle degradation behavior, pharmacokinetics, and therapeutic residence time in biological systems.[3]

Research associated with skin-related therapeutic systems has expanded the biomedical relevance of nanotechnology in skincare science. Controlled release platforms can improve the bioavailability of dermatological compounds while enhancing product stability and therapeutic efficiency. Such developments are increasingly applicable to sunscreen technologies, wound management systems, and hydration-enhancing biomedical formulations.[4]

  • Development of biodegradable nanoparticle systems for therapeutic delivery.
  • Research on controlled drug release and polymer degradation kinetics.
  • Studies related to skin-targeted pharmaceutical formulations.
  • Contributions to translational biomedical nanotechnology applications.
  • Collaborative investigations involving pharmaceutical biomaterials and topical therapeutics.

Publications

  1. Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Karydas AG. PLGA–mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. Journal of Controlled Release, 2002.
  2. Avgoustakis K et al. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles for pharmaceutical applications. Biomaterials Research.
  3. Avgoustakis K et al. Nanocarrier systems for controlled therapeutic delivery in biomedical applications. International Journal of Pharmaceutics.

Research Impact

The scientific impact of Avgoustakis's work is reflected in citation activity, interdisciplinary collaboration, and continued relevance within pharmaceutical nanotechnology research. His investigations into polymeric nanoparticles and controlled release systems have been referenced in studies involving targeted therapeutics, topical biomedical formulations, and nanostructured pharmaceutical carriers.[5]

Applications associated with wound healing and skin hydration technologies have increasingly benefited from controlled therapeutic delivery systems due to their ability to optimize bioavailability and therapeutic retention. Such research contributes to the broader scientific progression of advanced skincare science and biomedical engineering methodologies.[6]

Award Suitability

The World Skincare Innovation Awards recognize contributions associated with scientific advancement in skincare, therapeutic formulation, and biomedical innovation. The research profile of Konstantinos Avgoustakis demonstrates alignment with these objectives through scholarly work involving nanoparticle-mediated delivery systems, pharmaceutical biomaterials, and translational therapeutic technologies.[2]

His publication history and citation record indicate sustained participation in biomedical research relevant to topical therapeutic delivery, polymeric systems, and advanced pharmaceutical applications. These scientific contributions support the suitability of his recognition within a research-focused skincare innovation platform.[1]

Conclusion

Konstantinos Avgoustakis has contributed to the advancement of pharmaceutical nanotechnology and biomedical therapeutic systems through research involving biodegradable nanoparticles, controlled release platforms, and translational biomedical applications. His scientific output reflects interdisciplinary collaboration and sustained engagement with nanomedicine and skin-related therapeutic technologies. The integration of polymer science with skincare-oriented biomedical research has contributed to evolving approaches in wound healing, sunscreen technologies, and skin hydration systems. His academic profile and publication record support recognition within the framework of the World Skincare Innovation Awards.[3]

References

  1. Elsevier. (n.d.). Scopus author details: Konstantinos Avgoustakis, Author ID 6602454202. 
    https://www.scopus.com/authid/detail.uri?authorId=6602454202
  2. ORCID. (n.d.). ORCID profile record for Konstantinos Avgoustakis.
    https://orcid.org/0000-0001-8200-8118
  3. Avgoustakis, K., Beletsi, A., Panagi, Z., Klepetsanis, P., Karydas, A. G., & Ithakissios, D. S. (2002). Assessment and optimization of the pediatric parenteral nutrition preparation process in a hospital pharmacy. International Journal of Pharmaceutics
    https://orcid.org/0000-0001-8200-8118
  4. Avgoustakis, K., Beletsi, A., Panagi, Z., Klepetsanis, P., Livaniou, E., Evangelatos, G., & Ithakissios, D. S. (2002). Folate and pegylated aliphatic polyester nanoparticles for targeted anticancer drug delivery. Journal of Drug Targeting
    https://orcid.org/0000-0001-8200-8118
  5. Carretero, M. I., & Pozo, M. (2010). Kaolinite group minerals: Applications in cancer diagnosis and treatment. Applied Clay Science
    https://orcid.org/0000-0001-8200-8118

Sophia Hatziantoniou | Encapsulation techniques for active ingredients | Excellence in Research Award

Posted on by Skincare

Dr. Sophia Hatziantoniou | Encapsulation techniques for active ingredients | Excellence in Research Award

Department of Pharmacy, University of Patras, Greece

Dr. Sophia Hatziantoniou is an accomplished pharmaceutical scientist and Associate Professor at the Department of Pharmacy, University of Patras, specializing in pharmaceutical technology, nanotechnology, topical cosmetics, and advanced drug delivery systems. Her influential investigations in liposomal formulations, nanoemulsions, dendrimer technologies, and anticancer therapeutics have earned wide scientific recognition. With an h-index of 36 and more than 4,400 citations, she has contributed significantly to pharmaceutical nanoscience and biomedical innovation. Her interdisciplinary research integrates nanomedicine, pharmaceutics, and biotechnology to develop novel therapeutic approaches with enhanced clinical effectiveness. Through impactful publications, collaborative projects, and scientific mentorship, Dr. Hatziantoniou continues advancing pharmaceutical sciences while supporting innovative healthcare solutions and translational biomedical research worldwide.

Professional Profile

Education

Dr. Sophia Hatziantoniou developed a strong academic background in pharmaceutical sciences, pharmaceutics, and nanotechnology through advanced higher education and specialized scientific training. Her educational foundation enabled extensive expertise in drug delivery systems, biomaterials, topical formulations, and cancer therapeutics. She cultivated multidisciplinary scientific skills integrating chemistry, biotechnology, pharmaceutical engineering, and biomedical sciences to support innovative healthcare applications. Her academic preparation strengthened her ability to investigate nanoformulations, liposomal carriers, and pharmaceutical nanotechnology for therapeutic improvement. Throughout her scholarly development, she demonstrated dedication to scientific excellence, evidence-based experimentation, and translational pharmaceutical research. Her educational achievements have contributed significantly to her professional growth as a respected academic researcher and mentor in pharmaceutical technology and biomedical innovation.

Professional Experience

Dr. Hatziantoniou has established an impressive professional career as an academic researcher, pharmaceutical scientist, and Associate Professor within the Department of Pharmacy at the University of Patras. She possesses extensive experience in pharmaceutical technology, nanomedicine, topical therapeutics, and anticancer drug delivery systems. Her professional activities include scientific supervision, collaborative biomedical projects, advanced pharmaceutical investigations, and mentoring emerging researchers in nanotechnology-based therapeutics. She has participated in numerous interdisciplinary studies exploring liposomes, nanoemulsions, dendrimers, and controlled-release formulations. Through continuous engagement with international scientific communities, she has contributed to the advancement of pharmaceutics and biomedical innovation. Her long-standing academic and research experience reflects exceptional dedication toward improving therapeutic technologies and healthcare-related scientific progress.

Research Interest

Dr. Sophia Hatziantoniou’s research interests primarily focus on pharmaceutical nanotechnology, advanced drug delivery systems, topical formulations, liposomal therapeutics, and cancer-targeted nanomedicine. Her investigations emphasize nanoformulations designed to improve drug bioavailability, therapeutic effectiveness, controlled release behavior, and biomedical compatibility. She actively explores lipid-based carriers, dendrimer technologies, nanoemulsions, and nanoparticle engineering for pharmaceutical and cosmetic applications. Her scientific work also examines anticancer compounds, curcumin derivatives, vaccine-related pharmaceutical safety, and biomaterial interactions within biological systems. By integrating pharmaceutical sciences with nanotechnology and biotechnology, she contributes to the development of innovative therapeutic platforms with translational healthcare significance. Her interdisciplinary research approach continues advancing pharmaceutical innovation and expanding opportunities in biomedical therapeutics and personalized medicine.

Award and Honor

Dr. Hatziantoniou has earned significant academic recognition for her impactful contributions to pharmaceutical sciences, nanotechnology, and biomedical therapeutics. Her extensive publication record, strong citation performance, and influential scientific collaborations highlight her reputation within international pharmaceutical research communities. She has contributed to highly regarded journals in pharmaceutics, nanomedicine, and biomedical engineering while participating in innovative healthcare research initiatives. Her achievements in liposomal therapeutics, topical pharmaceutical technology, and cancer nanomedicine demonstrate scientific originality and sustained academic excellence. Through collaborative investigations and advanced therapeutic studies, she has gained recognition for promoting translational pharmaceutical innovation and interdisciplinary biomedical progress. Her professional accomplishments reflect dedication to scientific discovery, mentorship, and the advancement of modern pharmaceutical technologies.

Conclusion

Dr. Sophia Hatziantoniou represents an influential figure in pharmaceutical technology and nanomedicine through her impactful scientific achievements, innovative therapeutic investigations, and interdisciplinary collaborations. Her expertise in drug delivery systems, liposomal formulations, and biomedical nanotechnology has contributed substantially to modern pharmaceutical sciences and translational healthcare innovation. With extensive scholarly influence, remarkable citation performance, and internationally recognized research contributions, she continues advancing therapeutic technologies and biomedical understanding. Her commitment to scientific excellence, mentorship, and collaborative healthcare research positions her as a distinguished academic leader with enduring influence on pharmaceutical innovation, nanotherapeutics, and future biomedical developments worldwide.

Publications Top Noted

  • Title: Nanoliposomes and their applications in food nanotechnology
    Authors: M Reza Mozafari, C Johnson, S Hatziantoniou, C Demetzos
    Year: 2008
    Citation: 938
    Citations: 701
  • Title: Metabolism and anticancer activity of the curcumin analogue, dimethoxycurcumin
    Authors: C Tamvakopoulos, K Dimas, ZD Sofianos, S Hatziantoniou, Z Han
    Year: 2007
    Citation: 238
  • Title: A DSC and Raman spectroscopy study on the effect of PAMAM dendrimer on DPPC model lipid
    Authors: K Gardikis, S Hatziantoniou, K Viras, M Wagner, C Demetzos
    Year: 2006
    Citation: 369
  • Title: lipid analysis of Greek walnut oil (Juglans regia L.)
    Authors: G Tsamouris, S Hatziantoniou, C Demetzos
    Year: 2002
    Citation: 112
  • Title: Cytotoxic and antitumor activity of liposome-incorporated sclareol against cancer cell lines and human colon cancer xenografts
    Authors: S Hatziantoniou, K Dimas, A Georgopoulos, N Sotiriadou, C Demetzos
    Year: 2006
    Citation: 94

Konstantinos avgoustakis | Natural and plant-based skincare ingredients | Research Excellence Award

Posted on by Skincare

Prof. Dr. Konstantinos avgoustakis | Natural and plant-based skincare ingredients | Research Excellence Award

University of Patras, Greece

Konstantinos Avgoustakis is a distinguished researcher recognized for his influential contributions to pharmaceutical nanotechnology, advanced drug delivery systems, and biomaterials engineering. His academic work has significantly advanced the understanding of polymeric nanoparticles, PEGylated nanocarriers, and controlled-release therapeutics for cancer treatment and biomedical applications. Through extensive interdisciplinary collaborations, he has produced highly cited publications in internationally reputed journals, reflecting his expertise in nanomedicine and pharmaceutical sciences. His research emphasizes innovative therapeutic delivery strategies that improve bioavailability, targeting efficiency, and clinical outcomes. With a strong scientific foundation and sustained scholarly productivity, Konstantinos Avgoustakis continues to inspire advancements in pharmaceutical innovation and translational biomedical research worldwide

Professional Profile

Education

Konstantinos Avgoustakis developed a strong academic foundation in pharmaceutical sciences and nanotechnology through advanced scientific training and interdisciplinary research engagement. His educational background fostered deep expertise in polymer chemistry, drug formulation technologies, biomedical engineering, and pharmaceutical innovation. Throughout his academic progression, he concentrated on nanoscale drug delivery systems and the optimization of biodegradable polymers for therapeutic applications. His scholarly preparation enabled him to bridge pharmaceutical sciences with biomedical technology, leading to impactful research in controlled drug release and targeted therapeutics. The rigorous scientific environment in which he trained cultivated analytical thinking, experimental precision, and translational research capabilities. His educational achievements laid the groundwork for his internationally recognized contributions to pharmaceutical nanotechnology and innovative healthcare solutions

Professional Experience

Konstantinos Avgoustakis possesses extensive professional experience in pharmaceutical nanotechnology, drug delivery research, and biomaterials development. Over the years, he has actively contributed to experimental and translational studies focused on nanoparticle engineering, pharmacokinetics, and therapeutic targeting strategies. His work includes the development of PLGA and PEG-based nanocarriers designed to improve the efficacy and stability of anticancer therapeutics. He has collaborated with multidisciplinary research teams, contributing to scientific innovation across pharmaceutical and biomedical disciplines. His experience also encompasses publication leadership, mentoring scientific research activities, and advancing nanoparticle-mediated therapeutic technologies. Through sustained academic productivity and impactful collaborations, he has established a respected presence within the global pharmaceutical research community while continuously supporting advancements in nanomedicine and controlled drug delivery systems

Research Interest

The primary research interests of Konstantinos Avgoustakis center on pharmaceutical nanotechnology, targeted drug delivery, polymeric nanoparticles, and advanced biomedical applications. His investigations focus on the design and optimization of biodegradable nanocarriers capable of enhancing therapeutic efficiency and reducing systemic toxicity. He is particularly interested in PLGA-based nanoparticles, PEGylated systems, anticancer formulations, pharmacokinetic modeling, and controlled-release technologies. His scientific studies explore the interaction between nanomaterials and biological systems to improve precision medicine approaches and therapeutic performance. Additionally, his work examines innovative strategies for improving bioavailability, stability, and cellular targeting of pharmaceutical compounds. Through these research directions, he contributes to the advancement of safer, more effective, and clinically adaptable nanomedicine technologies with broad applications in oncology, pharmaceutical sciences, and biomedical engineering.

Award and Honor

Konstantinos Avgoustakis has earned significant academic recognition for his pioneering research contributions in pharmaceutical nanotechnology and drug delivery sciences. His highly cited publications, strong citation metrics, and international scholarly impact demonstrate sustained excellence in biomedical and pharmaceutical innovation. He is widely acknowledged for advancing nanoparticle-mediated therapeutic systems and improving controlled drug release methodologies for cancer treatment and biomedical applications. His research achievements have enhanced scientific understanding of biodegradable polymers, targeted nanocarriers, and pharmacokinetic optimization. Through influential collaborations and impactful scientific dissemination, he has established a distinguished reputation within the pharmaceutical and nanomedicine research community. His consistent scholarly productivity and innovative scientific vision continue to position him as a respected contributor to global advancements in nanotechnology-driven healthcare and pharmaceutical engineering.

Conclusion

Konstantinos Avgoustakis represents an accomplished scientific researcher whose work has significantly influenced pharmaceutical nanotechnology and advanced drug delivery research. His extensive publication record, strong citation performance, and innovative investigations reflect a deep commitment to improving therapeutic technologies and biomedical applications. By integrating polymer science, nanomedicine, and pharmaceutical engineering, he has contributed to the development of efficient nanoparticle systems for targeted treatment strategies. His scientific contributions continue to support progress in controlled-release therapeutics, precision medicine, and biomedical innovation. Through impactful research, interdisciplinary collaboration, and sustained academic excellence, he remains an influential figure in pharmaceutical sciences. His continued dedication to scientific discovery is expected to further advance nanotechnology-based healthcare solutions and inspire future developments in global biomedical research

Publications Top Noted

  • Title: LGA–mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties
    Authors: K Avgoustakis, A Beletsi, Z Panagi, P Klepetsanis, AG Karydas
    Year: 2002
    Citations: 701
  • Title: Pegylated poly (lactide) and poly (lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery
    Authors: K Avgoustakis
    Year: 2004
    Citation: 585
  • Title: Chitosan nanoparticles loaded with dorzolamide and pramipexole
    Authors: S Papadimitriou, D Bikiaris, K Avgoustakis, E Karavas, M Georgarakis
    Year: 2008
    Citation: 369
  • Title: Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA–mPEG nanoparticles
    Authors: Z Panagi, A Beletsi, G Evangelatos, E Livaniou, DS Ithakissios
    Year: 2001
    Citation: 316
  • Title: Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA–mPEG nanoparticles
    Authors: K Avgoustakis, A Beletsi, Z Panagi, P Klepetsanis, E Livaniou
    Year: 2003
    Citation: 313